Sign In

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.


EryDel S.p.A. awarded at Healthcare Biotech Forum

On 30 and 31 March 2009 EryDel SpA, a spin-off of the University of Urbino, took part in Biotech Healthcare Forum, an initiative promoted by the Agency for the Promotion of European Research (APRE), which was held in Rome, winning the Best Presentation Award. It was given by a panel of international reviewers and it is expression of the great interest that the project has generated.
EryDel S.p.A. was founded in March 2007 by the initiative of Prof. Mauro Magnani and Prof. Luigia Rossi of the Urbino University 'Carlo Bo'. The company operates in the field of Biotech Pharmaceuticals using autologous red blood cells (from the same patient) to deliver and administer innovative therapies. The technology is covered by worldwide patents and has already a large number of potential applications in the pipeline.
Healthcare Biotech Forum ( as well as being a showcase for innovation in the field of Health Biotechnology, is an important opportunity to make known innovative companies and researchers to an audience of experts from across Europe, big pharma companies and venture capitalists.
The company General Manager, Dr. Giovanni Mambrini, welcomes the award and expresses great satisfaction for the first results achieved by the company which is currently engaged in the realization of an European Multicentre Phase III Clinical Study on Inflammatory Bowel Diseases (Crohn Disease). The objectives of the study concern the possibility of encapsulating an anti-inflammatory drug (a corticosteroid analogue) in red blood cells and thereby obtaining a low and constant release into the circulation (up to 30 days). In this way a nearly complete reduction of serious side effects of these drugs, which are mainly shown following their chronic intake, is obtained.

Publisher Contact Information:

+39 348 5124565

Company profile of EryDel
Past press releases of EryDel.


Tech investments
From our Online Data Service
VC-backed companies
From our Radar

Recent Deals

Mar 24€1.8MInternet services
Mar 22€1.8MOther Biotechnology & Healthcare
Mar 22N/AMedical devices
Mar 22N/AConsumer applications
Mar 22N/ANetwork management
Mar 21€3.3MGames
Mar 21€16.0MInternet services

For information on Europe's most extensive database on technology funding click here!


Press Releases

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

Jan 2
Urban Jungle
urban jungle raises 1m in seed funding to build tech-enabled home ...

Aug 17
Komed Health
komed health closes seed financing round

Jul 10
Komed Health
komed health to be supported by nokia and deutsche telekom

About usContact usLegal Information
Copyright 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.